ScholarIQanswers from OpenAlex & ORCID
Sten Madsbad
ResearcherPublications, citations & collaboration network
Sten Madsbad is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Sten Madsbad have?
ScholarIQindexed works
Sten Madsbad has 807 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Sten Madsbad have?
ScholarIQcitation count
Sten Madsbad has 37,976 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Sten Madsbad?
ScholarIQh-index
Sten Madsbad has an h-index of 101 in OpenAlex.
What is the i10-index of Sten Madsbad?
ScholarIQi10-index
Sten Madsbad has an i10-index of 434 in OpenAlex.
What is the ORCID of Sten Madsbad?
ScholarIQorcid
The ORCID for Sten Madsbad is on the source record.
What is the OpenAlex record for Sten Madsbad?
ScholarIQopenalex
The OpenAlex for Sten Madsbad is on the source record.
What are the most-cited papers on Sten Madsbad?
ScholarIQmost cited works
Angiotensin-Receptor Blockade versus Converting–Enzyme Inhibition in Type 2 Diabetes and Nephropathy
Anthony Barnett, Stephen C. Bain, Paul Bouter, Bengt E. Karlberg, Sten Madsbad, J Jervell, Jukka Mustonen
Reduced Postprandial Concentrations of Intact Biologically Active Glucagon-Like Peptide 1 in Type 2 Diabetic Patients
Tina Vilsbøll, Thure Krarup, Carolyn F. Deacon, Sten Madsbad, Jens J. Holst
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
Carel W. le Roux, Carel W le Roux, Arne Astrup, Ken Fujioka, Frank Greenway, David C W Lau, Luc Van Gaal, Rafael Violante Ortíz, John P H Wilding, Trine Vang Skjøth, Linda Shapiro Manning, Xavier Pi-Sunyer, A. Hamann, Alain Barakat, Matthias Blüher, Thomas Linn, Andrea Mölle, Alexander Segner, Petra Stübler, Regina Tosch-Sisting, Furio Pacini, Ferruccio Santini, Giulio Marchesini, Carlo Maria Rotella, Cecilia Invitti, Roberto Vettor, Silvio Buscemi, Pedro Mezquita Raya, Felipe Casanueva Freijoo, Ramón Gomis de Barbará, Raffaele Carraro, Enrique Romero Bobillo, Carmen de la Cuesta, Csaba Farsang, Albert Császár, Barbara Zahorska‐Markiewicz, Danuta Pupek-Musialik, Edward Franek, Lucyna Ostrowska, Magdalena Olszanecka‐Glinianowicz, Nebojša Lalić, Dragan Micić, Bernhard Ludvik, Bernhard Paulweber, Rudolf Prager, André Scheen, Luc Van Gaal, Arne Vernon Astrup, Kjeld Hermansen, Sten Madsbad, Aila Rissanen, Sakari Nieminen, Markku J. Savolainen, Michel Krempf, Monique Romon, M. Laville, Michel Marre, R Mira, Francis Finucane, Aletha Veenendaal, Frank van Berkum, Solrun Johannsson-Vidarsdóttir, V. Van de Walle, Eelco W. Meesters, Jøran Hjelmesæth, Tor Ole Klemsdal, Bård Kulseng, Birgit Bach-Kliegel, Kurt Laederach, Lukas Villiger, Alain Golay, Stefan Bilz, Thozhukat Sathyapalan, Stephen C. Bain, Sudesh Kumar, Carel Wynard Le Roux, Carel Wynard Le Roux, Michael E.J. Lean, Barbara McGowan, Tariq Rehman, John Wilding, Gary Wittert, Ian Caterson, Joeseph Proietto, John Prins, Bruno Geloneze Neto, Jorge Luiz Gross, Antônio Roberto Chacra, Alfredo Halpern, Henrique Suplicy, Francis Chun Chung Chow, Hemant Thacker, Manoj Chadha, Hemaraj Chandalia, Ambika Unnikrishnan, Sanjay Kalra, Neeta Deshpande, Minakshi Shunmugavelu, Vaishali Deshmukh, Maximo Maislos
Incretin Secretion in Relation to Meal Size and Body Weight in Healthy Subjects and People with Type 1 and Type 2 Diabetes Mellitus
Tina Vilsbøll, Thure Krarup, Jesper Sonne, Sten Madsbad, Aage Vølund, Annegrete Juul, Jens J. Holst
Liraglutide, a Long-Acting Human Glucagon-Like Peptide-1 Analog, Given as Monotherapy Significantly Improves Glycemic Control and Lowers Body Weight Without Risk of Hypoglycemia in Patients With Type 2 Diabetes
Tina Vilsbøll, Milan Zdravkovic, T Le-Thi, Thure Krarup, Ole Schmitz, J.P. Courrèges, Rob H.A. Verhoeven, Ingrid Bugáňová, Sten Madsbad